Development of the Roadmap

Professor Anne Cust, co-lead of the Prevention, Risk & Clinical Detection of Melanoma stream at Melanoma Institute Australia, will lead the program on behalf of the Institute. Governance Committees and Workstreams have been established (see more information in summary below), drawing upon a very diverse range of experts who will be tasked with evaluating and collating the evidence and making recommendations on the design of the Roadmap. Stakeholders from all possible touchpoints along a potential screening pathway will also be meaningfully and frequently consulted by the Roadmap teams to seek their input, insights and feedback to ensure a feasible and sustainable screening program can be designed.